Richard T Kenney - Net Worth and Insider Trading
Richard T Kenney Net Worth
The estimated net worth of Richard T Kenney is at least $35 dollars as of 2025-01-03. Richard T Kenney is the Chief Medical Officer of Sonnet BioTherapeutics Holdings Inc and owns about 20 shares of Sonnet BioTherapeutics Holdings Inc (SONN) stock worth over $35. Details can be seen in Richard T Kenney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard T Kenney has not made any transactions after 2021-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard T Kenney
Richard T Kenney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard T Kenney owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of Richard T Kenney’s form 4 insider trades.
Insider Ownership Summary of Richard T Kenney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2021-06-09 | Chief Medical Officer |
Richard T Kenney Latest Holdings Summary
Richard T Kenney currently owns a total of 1 stock. Richard T Kenney owns 20 shares of Sonnet BioTherapeutics Holdings Inc (SONN) as of June 9, 2021, with a value of $35.
Latest Holdings of Richard T Kenney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2021-06-09 | 20 | 1.75 | 35 |
Holding Weightings of Richard T Kenney
Richard T Kenney Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard T Kenney has made a total of 2 transactions in Sonnet BioTherapeutics Holdings Inc (SONN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sonnet BioTherapeutics Holdings Inc is the acquisition of 6 shares on June 9, 2021, which cost Richard T Kenney around $23,100.
Insider Trading History of Richard T Kenney
- 1
Richard T Kenney Trading Performance
GuruFocus tracks the stock performance after each of Richard T Kenney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard T Kenney is -40.06%. GuruFocus also compares Richard T Kenney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard T Kenney within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard T Kenney's insider trading performs compared to the benchmark.
Performance of Richard T Kenney
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.81 | | | | | |
| Relative Return to S&P 500(%) | -11.2 | | | | | |
Richard T Kenney Ownership Network
Richard T Kenney Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Richard T Kenney is the Chief Medical Officer of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Richard T Kenney Mailing Address
Above is the net worth, insider trading, and ownership report for Richard T Kenney. You might contact Richard T Kenney via mailing address: C/o Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
